Psychedelic Drugs: Considerations for Clinical Investigations; Draft Guidance for Industry; Availability
🏛 Food and Drug Administration (FDA)FDA-2023-D-1987
Documents
3
Total comments
1
all analyzed
Comment status
Open
Last activity
Jul 15, 2026
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
OtherJul 14, 2026
Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Final GuidanceNo comment period💬 1 comment
- Notice· Jul 14, 2026No comment period
- Other· Jun 26, 2023Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Draft Guidance→Closed on Aug 26, 2023